Envoy Medical, Inc. (COCH)

NCM – Real vaqt narxi. Valyuta: USD

0.75

-0.02 (-3.21%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

0.73

-0.01 (-1.99%)

Bozordan keyin: Aug 12, 2026, 6:33 PM EDT

10.08.2026

Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates

Envoy Medical, Inc. (COCH) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.32 per share a year ago.

10.08.2026

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Submitted First Module of Modular PMA Application to FDA Subsequent to Quarter End, the Company Reported Positive 12-Month Stage 1 Data Showing Continued Improvement in Speech Perception White Bear Lake, Minnesota--(Newsfile Corp. - August 10, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today reported financial results for the second quarter ended June 30, 2026, and provided a business update, highlighting continued execution on its corporate initiatives. "The second quarter moved us measurably closer to bringing our fully implanted cochlear implant to market," said Brent Lucas, Chief Executive Officer of Envoy Medical.

Videolar

No Data

There is no data to display

Press-relizlar

10.08.2026

Envoy Medical, Inc. (COCH)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Envoy Medical, Inc. (COCH)

Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Videolar

No Data

Press-relizlar

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Videolar

No Data

Press-relizlar

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Search stocks

Envoy Medical, Inc. (COCH)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Envoy Medical, Inc. (COCH)

Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Videolar

No Data

Press-relizlar

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Videolar

No Data

Press-relizlar

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones